The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease. The Absorb GT1 Bioresorbable Vascular Scaffold System (BVS), which releases the drug everolimus to limit the growth of scar tissue, is gradually absorbed by the body in approximately three years.
Cumberland Farms Announces Voluntary Recall of its Sea Salt Caramel Delights Flavor of Cumberland Farms Premium Chocolate Treats Due to Possible Presence of Peanuts
Cumberland Farms announces a voluntary recall of its SEA SALT CARAMEL DELIGHTS flavor of Cumberland Farms Farmhouse Premium Chocolate Treats due to concerns of the possible presence of peanuts. People who have an allergy or severe sensitivity to specific types of allergen, such as peanuts, run the risk of serious life threatening allergic reactions if they consume the product being recalled.
Cumberland Farms Announces Voluntary Recall if it’s Sea Salt Caramel Delights Flavor of Cumberland Farms Premium Chocolate Treats Due to Possible Presance of Peanuts
Cumberland Farms announces a voluntary recall of its SEA SALT CARAMEL DELIGHTS flavor of Cumberland Farms Farmhouse Premium Chocolate Treats due to concerns of the possible presence of peanuts. People who have an allergy or severe sensitivity to specific types of allergen, such as peanuts, run the risk of serious life threatening allergic reactions if they consume the product being recalled.
Dream Body Weight Loss Issues Voluntary Nationwide Recall of Dream Body 450mg, Dream Body Extreme Gold 800mg, Dream Body Advanced 400mg Due to Undeclared Sibutramine
Grand Prairie, TX, Dream Body Weight Loss is voluntarily recalling all lots of Dream Body Extreme Gold 800mg 30 gold capsules, Dream Body 450mg 30 white capsules, and Dream Body Advanced 400mg 30 purple capsules to the consumer level. The Dream Body Extreme 800mg Gold, Dream Body 450mg and Dream Body Advanced 400mg have been found to contain sibutramine after FDA sampling and testing.
General Mills Expands Flour Recall to Include Additional Dates from Last Fall
General Mills of Minneapolis, MN, continues to collaborate with health officials to investigate a multistate outbreak of E. coli O121, and is expanding its recall of Gold Medal flour, Wondra flour, and Signature Kitchens flour to include flour made earlier in the fall that may still be in consumers’ pantries. The recall is being expanded due to a newly-reported illness that appears to have stemmed from the consumption of raw dough or batter linked to flour produced last fall.
Eastland Food Corp. Issues Allergy Alert on Undeclared Milk in Euro Custard Cakes
Eastland Food Corp. (Columbia, Maryland) is announcing a limited voluntary recall of a single lot of Euro Custard Cake because it contains an undeclared milk ingredient. People who have an allergy or severe sensitivity to milk run the risk of a serious or life threatening allergic reaction if they consume the affected Euro Custard Cake.
FDA clears first test to detect specific genetic markers for certain antibiotic-resistant bacteria directly from clinical specimens
The U.S. Food and Drug Administration today cleared for marketing the Xpert Carba-R Assay, an infection control aid that tests patient specimens to detect specific genetic markers associated with bacteria that are resistant to Carbapenem antibiotics. Carbapenem antibiotics are widely used in hospitals to treat severe infections. These resistant organisms are commonly referred to as Carbapenem-resistant Enterobacteriaceae, or CRE, and have been reported in almost all states within the U.S.
FDA clears first test to detect specific genetic markers for certain antibiotic-resistant bacteria directly from clinical specimens
The U.S. Food and Drug Administration today cleared for marketing the Xpert Carba-R Assay, an infection control aid that tests patient specimens to detect specific genetic markers associated with bacteria that are resistant to Carbapenem antibiotics. Carbapenem antibiotics are widely used in hospitals to treat severe infections. These resistant organisms are commonly referred to as Carbapenem-resistant Enterobacteriaceae, or CRE, and have been reported in almost all states within the U.S.
FDA approves implantable device that changes the shape of the cornea to correct near vision
The U.S. Food and Drug Administration today approved the Raindrop Near Vision Inlay, a device implanted in the cornea (the clear, front surface) of one eye to improve near vision in certain patients with presbyopia. It is the second FDA-approved implantable corneal device for correction of near vision in patients who have not had cataract surgery and the first implantable device that changes the shape of the cornea to achieve improved vision.
FDA approves implantable device that changes the shape of the cornea to correct near vision
The U.S. Food and Drug Administration today approved the Raindrop Near Vision Inlay, a device implanted in the cornea (the clear, front surface) of one eye to improve near vision in certain patients with presbyopia. It is the second FDA-approved implantable corneal device for correction of near vision in patients who have not had cataract surgery and the first implantable device that changes the shape of the cornea to achieve improved vision.